ATE441437T1 - Verfahren zur identifizierung von respondern auf die behandlung mti insulinsensibilisatoren - Google Patents
Verfahren zur identifizierung von respondern auf die behandlung mti insulinsensibilisatorenInfo
- Publication number
- ATE441437T1 ATE441437T1 AT04810280T AT04810280T ATE441437T1 AT E441437 T1 ATE441437 T1 AT E441437T1 AT 04810280 T AT04810280 T AT 04810280T AT 04810280 T AT04810280 T AT 04810280T AT E441437 T1 ATE441437 T1 AT E441437T1
- Authority
- AT
- Austria
- Prior art keywords
- adiponectin
- amount
- therapeutic treatment
- patient
- mti
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 229940122355 Insulin sensitizer Drugs 0.000 title 1
- 102000011690 Adiponectin Human genes 0.000 abstract 9
- 108010076365 Adiponectin Proteins 0.000 abstract 9
- 230000001225 therapeutic effect Effects 0.000 abstract 6
- 210000002966 serum Anatomy 0.000 abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
- 206010022489 Insulin Resistance Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51839003P | 2003-11-07 | 2003-11-07 | |
| PCT/US2004/036648 WO2005046734A1 (en) | 2003-11-07 | 2004-11-04 | Method of identifying responders to treatment with insulin sensitizers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE441437T1 true ATE441437T1 (de) | 2009-09-15 |
Family
ID=34590257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04810280T ATE441437T1 (de) | 2003-11-07 | 2004-11-04 | Verfahren zur identifizierung von respondern auf die behandlung mti insulinsensibilisatoren |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20070098636A1 (de) |
| EP (1) | EP1684807B1 (de) |
| JP (1) | JP4397934B2 (de) |
| CN (1) | CN1882363A (de) |
| AT (1) | ATE441437T1 (de) |
| AU (1) | AU2004289237C1 (de) |
| BR (1) | BRPI0416248A (de) |
| CA (1) | CA2545065C (de) |
| DE (1) | DE602004022968D1 (de) |
| WO (1) | WO2005046734A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008273938A (ja) * | 2007-03-30 | 2008-11-13 | Shiseido Co Ltd | アディポネクチン産生促進剤 |
| WO2008156617A2 (en) * | 2007-06-15 | 2008-12-24 | Smithkline Beecham Corporation | Methods and kits for predicting treatment response in type ii diabetes mellitus patients |
| US20080312154A1 (en) * | 2007-06-15 | 2008-12-18 | Barbara Lee Peterlin | Administration of adipocytokine and adiponectin for treating headache and methods of diagnosing headache by measuring adiponectin |
| CN101932728B (zh) | 2007-11-30 | 2013-06-19 | 西门子医疗保健诊断公司 | 脂连蛋白受体片段和使用方法 |
| WO2010123720A1 (en) | 2009-04-23 | 2010-10-28 | Siemens Healthcare Diagnostics Inc. | Monomeric and dimeric forms of adiponectin receptor fragments and methods of use |
| AU2009325962A1 (en) * | 2008-12-11 | 2011-07-28 | Ikfe Institut Fur Klinische Forschung Und Entwicklung Gmbh | Biomarkers for insulin sensitizer drug response |
| EP2382467A1 (de) * | 2008-12-30 | 2011-11-02 | IKFE GmbH | Biomarker für fettgewebeaktivität |
| JP7116413B2 (ja) * | 2018-03-02 | 2022-08-10 | 株式会社山田養蜂場本社 | 選別方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1426764T3 (da) | 2001-08-17 | 2011-06-27 | Fujirebio Kk | Fremgangsmåde til diagnosticering eller monitorering af fejl i sukkermetabolisme |
| JP4677545B2 (ja) * | 2003-10-15 | 2011-04-27 | 積水メディカル株式会社 | 多量体アディポネクチンの分別測定方法 |
-
2004
- 2004-11-04 EP EP04810280A patent/EP1684807B1/de not_active Expired - Lifetime
- 2004-11-04 JP JP2006538465A patent/JP4397934B2/ja not_active Expired - Fee Related
- 2004-11-04 CN CNA2004800324005A patent/CN1882363A/zh active Pending
- 2004-11-04 DE DE602004022968T patent/DE602004022968D1/de not_active Expired - Lifetime
- 2004-11-04 AT AT04810280T patent/ATE441437T1/de not_active IP Right Cessation
- 2004-11-04 AU AU2004289237A patent/AU2004289237C1/en not_active Ceased
- 2004-11-04 US US10/578,811 patent/US20070098636A1/en not_active Abandoned
- 2004-11-04 CA CA2545065A patent/CA2545065C/en not_active Expired - Fee Related
- 2004-11-04 BR BRPI0416248-0A patent/BRPI0416248A/pt not_active IP Right Cessation
- 2004-11-04 WO PCT/US2004/036648 patent/WO2005046734A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004289237A1 (en) | 2005-05-26 |
| AU2004289237C1 (en) | 2009-02-26 |
| EP1684807A4 (de) | 2008-03-19 |
| JP2007510906A (ja) | 2007-04-26 |
| EP1684807A1 (de) | 2006-08-02 |
| JP4397934B2 (ja) | 2010-01-13 |
| WO2005046734A1 (en) | 2005-05-26 |
| AU2004289237B2 (en) | 2008-08-21 |
| BRPI0416248A (pt) | 2007-01-09 |
| CA2545065A1 (en) | 2005-05-26 |
| US20070098636A1 (en) | 2007-05-03 |
| CA2545065C (en) | 2012-07-17 |
| EP1684807B1 (de) | 2009-09-02 |
| DE602004022968D1 (de) | 2009-10-15 |
| CN1882363A (zh) | 2006-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Walker et al. | Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice | |
| Takeuchi et al. | The prevalence of frailty and its associated factors in Japanese hemodialysis patients | |
| Newgard et al. | Revisiting the “golden hour”: an evaluation of out-of-hospital time in shock and traumatic brain injury | |
| Ansell et al. | Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines | |
| Ordonez et al. | Aerobic training improved low‐grade inflammation in obese women with intellectual disability | |
| Plowman | Is there a role for exercise in the management of bulbar dysfunction in amyotrophic lateral sclerosis? | |
| Meesters et al. | The effect of Mindfulness-Based Stress Reduction on wound healing: a preliminary study | |
| Ventä et al. | Oral piercings among first-year university students | |
| ATE441437T1 (de) | Verfahren zur identifizierung von respondern auf die behandlung mti insulinsensibilisatoren | |
| Stener-Victorin et al. | Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial | |
| DE69230000D1 (de) | Verfahren und testsatz zur messung von endogenen zytokinen | |
| AI-Khawaja et al. | The Barthel Index and its relationship to nursing dependency in rehabilitation | |
| Khanum et al. | Effects of diaphragmatic breathing exercises on blood sugar levels in working class females with type-2 diabetes mellitus | |
| Burton | The external examination: An often-neglected autopsy component | |
| Rosyanti et al. | The Effectiveness of Complementary" Cupping Therapy" On The Community's Routine Blood Hematology Status During The COVID-19 Pandemic | |
| DE502004012230D1 (de) | Verfahren zur diagnose von erkrankungen unter bestimmung von apolipoprotein c-i | |
| Ilkafah et al. | Analysis of Factors Related to Self Management Behavior (SMB) in Hypertensive Patients | |
| Özkaptan et al. | Attitudes of nursing students towards older people in Turkey | |
| Sharma | Patient Satisfaction and Oral Health-related Quality of Life (ohrqol) of Edentulous People after Mandibular Denture Relining With a Soft-liner Material: A Pilot Study | |
| Spasovska Trajanovska et al. | Plasma cortisol levels in heroin addicts | |
| Van Hattum | Health strategy on HCV in The Netherlands | |
| Batool | Factors Responsible for Tooth Extraction Among Patients of Dental Disease | |
| Amsler et al. | OP0149 VISUAL LOSS IN PATIENTS WITH GIANT CELL ARTERITIS TREATED WITH TOCILIZUMAB | |
| Moore et al. | Fear 0finjectionSand fep0t0f negative dentiSt behaV0fam0ng CaUC3Sian | |
| Head | DISEASES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |